Cofirasersen
Cofirasersen is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2247669-96-9
- Fòrmula: C172H218N57O88P15S15
- Peso molecular:5437.55
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 2247669-96-9
-
Peso molecular 5437.55
-
Fòrmula C172H218N57O88P15S15
-
SMILES
[Cofirasersen]
-
Synonyms
ION-827359
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)